1 completed, 1 recruiting, 1 terminated. 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Phase 3 | 2 | Recruiting 1, Terminated 1 |
Follow Clonidine HCL: new trials by email Literature Review of Clonidine HCL trials Research Report on Clonidine HCL
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| R.E.C.K vs Exparel in Robotic Nephrectomy Ropivacaine HCL, Exparel, Epinephrine - Renal Carcinoma, Nephrectomy / Methods | Phase 3 | Recruiting | Wake Forest University Health Sciences | 170 | 2025-11-14 | 2026-07-13 |
| Clonidine to Treat Iatrogenic-induced Opioid Dependence in Infants Clonidine HCL, saline - Neonatal Abstinence Syndrome | Phase 2 / Phase 3 | Terminated | Johns Hopkins University | 12 | 2011-07-01 | 2017-09-13 |
| Clonidine as Adjunct Therapy for the Treatment of Neonatal Abstinence Syndrome Clonidine HCL - Neonatal Abstinence Syndrome | Phase 2 | Completed | National Institute on Drug Abuse (NIDA) | 80 | 2002-07-01 | 2017-01-11 |
Neonatal Abstinence Syndrome (2) · Agnosia (1) · Carcinoma, Renal Cell (1) · Psychomotor Agitation (1)
Johns Hopkins University (1) · National Institute on Drug Abuse (NIDA) (1) · Wake Forest University Health Sciences (1)
United States (3)
Estelle B Gauda, M.D. (1) · Estelle B Gauda, MD (1) · Roy Ornob, MD (1)
R21DA016288 (1), R21DA029295 (1)